Study Coordinator - Image Diagnosis and Nuclear Medicine (20 h/week)

Ref: 24-124_SS_MC

About the research group

Image diagnosis and nuclear medicine

Nuclear Medicine Department in HUB (Hospital Universitari de Bellvitge) has significant accumulated experience in diagnostic imaging field and also in nuclear medicine therapies, being a point of reference in Catalonia and Spain.
Nowadays it has been in a more close contact with Catalan Institute of Oncology (ICO) due to the increase of clinical trials in early phases.
In the diagnostic field, Nuclear Medicine Department in HUB it was the first center to have the first public PET/CT installed in Spain in 2003. The increase of demand for PET scans motivated the installation of the second PET/CT in 2016, making it the first public center with two PET/CTs. It is a pioneer in PET/CT studies, currently performing more than 9,000 PET scans per year, serving a wide geographical area of Catalonia, more than 15,000 scintigraphic scans and more than 1,000 leucocytes/erythrocytes radiolabellings. At the end of 2022, it will become the center of High Diagnostic Accuracy with the installation of the first PET/MRI equipment in Spain, which will serve the entire Catalan public system, generating a unique portfolio.
In the field of metabolic therapy, the HUB currently has a short-stay metabolic therapy room for outpatients and two metabolic therapy rooms for inpatients located at the Duran i Reynals Hospital (ICO-Hospitalet). He was one of the participants, starting in 2013, in the pioneering international study NETTER-1, the first to demonstrate on a large scale the positive effects of [177Lu]Lu-DOTA-TATE in neuroendocrine tumors. Since 2017, a conventional care program for the application of this treatment has been in place, coordinated with oncology specialists from the ICO-Hospitalet. It has currently reached 100 conventional healthcare treatments, to which must be added about fifty treatments carried out as part of clinical trials. This boom means that nuclear medicine therapies with new radiopharmaceuticals are also beginning to be used in prostate cancer and are being tested for breast, lung, esophagus, pancreas and glioblastoma, among others, in which the nuclear medicine service of the HUB is participating.
ICO-L’Hospitalet is a reference hospital for the clinical research in cancer. Their two units (UIC and UFF1) have been participating in 596 clinical trials with active recruitment or with current activities during 2022 and 681 patients decided to participate in them. Many of these trials are testing the most promising therapies in cancer and investigators involved in them are specialized and up-to-date with the latest advances in new treatments. UIC and UFF1 units they are the best professionals who carry out the most demanding clinical trials.

About the role

• Coordination of Nuclear Medicine/Oncology Clinical Trials ( Nuclear Medicine Department ) for early phases or for advanced phase trials.
o Performance and application of coordinated procedures between the different clinical services involved in the inclusion, treatment and follow-up of patient’s participation.
o Support to Investigators and electronic tools implementation.
o Management of human tissues between different external referring sites.
• Record of transactions in sponsor’s systems (IWR). Record of trial and patient’s information into clinical and research applications.
• Administrative procedures during the study
• SAE completion
• Case Report Form training, completion and correction. Queries resolution.
• Imaging uploading into different digital platforms
• Sample handling
• Samples shipment
• Communication with Sponsors and CROs.
• Preparation and attention to monitoring visits, audits and inspections, internal and external information meetings.

Job requirements

Professional experience

• Experience in nuclear medicine department
  
• Experience in uploading images in digital platforms
  
• Experience in using PET/CT and/or nuclear medicine equipments

Education and training

• Education: Imaging Technician or Laboratory Technician
  
• Radioactive facilities Operator license 

Technical & soft skills

• Internet Browsers (Firefox, Chrome, Edge) and Patients Files

Languages

• Good command of the English language

We will value, but not required

• Education in nuclear medicine clinical trials will be valued
  
• Experience in handling and shipment samples will be valued
  
• Education in Good Clinical Practices will be valued
  
• Familiarity with SAP Argos Electronic Medical Record system

What do we offer

• No. of positions: 1

• Estimated start date: 04/11/2024

• Contract duration: 6 months

• Estimated annual gross salary: 13.190 €

• You will be part of a multicultural team. We have a fun loving and friendly international work environment.

• Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.

• Possibility to work some days in remote -Teleworking

• 26 working days of holiday per year

• System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.

• Paid leave package

• Benefits of constant training are offered

• We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.
  

Deadline: Please submit your application by  26/10/2024

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations:

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).